Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Ordinary shares, nominal value of GBP0.002 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
80
-
Total shares
-
26.3M
-
Shares change
-
+4.44M
-
Total reported value, excl. options
-
$1.24B
-
Value change
-
+$213M
-
Put/Call ratio
-
5.07
-
Number of buys
-
49
-
Number of sells
-
-28
-
Price
-
$46.94
Significant Holders of Immunocore Holdings plc - Ordinary shares, nominal value of GBP0.002 per share (IMCR) as of Q3 2022
85 filings reported holding IMCR - Immunocore Holdings plc - Ordinary shares, nominal value of GBP0.002 per share as of Q3 2022.
Immunocore Holdings plc - Ordinary shares, nominal value of GBP0.002 per share (IMCR) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.3M shares
of 54.8M outstanding shares and own 48.09% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4.45M shares), Rock Springs Capital Management LP (3.49M shares), BAKER BROS. ADVISORS LP (2.52M shares), Avidity Partners Management LP (2.08M shares), FMR LLC (1.39M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.16M shares), COWEN AND COMPANY, LLC (1.01M shares), GENERAL ATLANTIC, L.P. (950K shares), FIRST MANHATTAN CO (796K shares), and Paradigm Biocapital Advisors LP (773K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.